| Literature DB >> 27819381 |
M V B Malachias, M A M Gomes, F Nobre, A Alessi, A D Feitosa, E B Coelho.
Abstract
Entities:
Mesh:
Year: 2016 PMID: 27819381 PMCID: PMC5319466 DOI: 10.5935/abc.20160152
Source DB: PubMed Journal: Arq Bras Cardiol ISSN: 0066-782X Impact factor: 2.000
INMETRO ordinances n. 24, of February 22, 1996, for mechanical aneroid sphygmomanometers, and n. 96, of March 20, 2008, for digital electronic sphygmomanometers for non-invasive measurement.
| By means of these ordinances, the manufacturers
or importers of sphygmomanometers should submit their
products to metrological control, defined in Technical
|
| Technical appreciation of the model – every
manufacturer or importer of sphygmomanometers should submit
each model manufactured or imported to INMETRO
|
| Initial verification – should be performed in
all sphygmomanometers inside the manufacturer’s facilities
or any other place at INMETRO’s discretion before their
|
| Periodical verification – should be performed once a year, preferably inside the RBMLQ agency (IPEM) or any other place at INMETRO’s discretion; and |
| Occasional verification – should be performed at the owner’s request, after device repair and/or maintenance, or when INMETRO deems it necessary. |
| RBMLQ: Brazilian Legal Metrology and Quality Network; IPEM: State Department of Weights and Measures |
Correction factors of BP measurement with standard adult cuff ( width, 13 cm, and length, 30 cm), according to patient’s arm circumference
| Circumference (cm) | Correction factor (mm Hg) | |
|---|---|---|
| SBP | DBP | |
| 26 | +5 | +3 |
| 28 | +3 | +2 |
| 30 | 0 | 0 |
| 32 | -2 | -1 |
| 34 | -4 | -3 |
| 36 | -6 | -4 |
| 38 | -8 | -6 |
| 40 | -10 | -7 |
| 42 | -12 | -9 |
| 44 | -14 | -10 |
| 46 | -16 | -11 |
| 48 | -18 | -13 |
Cuff dimensions (bladder width and length) according to arm circumference
| Arm circumference (cm) | Cuff denomination | Bladder width (cm) | Bladder length (cm) |
|---|---|---|---|
| ≤ 6 | Newborn | 3 | 6 |
| 6-15 | Infant | 5 | 15 |
| 16-21 | Child | 8 | 21 |
| 22-26 | Small adult | 10 | 24 |
| 27-34 | Adult | 13 | 30 |
| 35-44 | Large adult | 16 | 38 |
| 45-52 | Thigh | 20 | 42 |
Reference values for the definition of AH based on office, ABPM and HBPM measurements
| Category | SBP (mm Hg) | DBP (mm Hg) | |
|---|---|---|---|
| Office | ≥ 140 | and/or | ≥ 90 |
| ABPM | |||
| Wakefulness | ≥ 135 | and/or | ≥ 85 |
| Sleep | ≥ 120 | and/or | ≥ 70 |
| 24 hours | ≥ 130 | and/or | ≥ 80 |
| HBPM | ≥ 135 | and/or | ≥ 85 |
SBP: systolic blood pressure; DBP: diastolic blood pressure.
Clinical indications for outside-the-office BP measurement aimed at diagnosis[9,10,18]
| Suspected WCH |
| - office stage 1 AH |
| - office high BP in asymptomatic individuals with no TOD and low total CV risk |
| Suspected MH |
| - office BP between 130/85 and 139/89 mm Hg |
| - office BP < 140/90 mm Hg in asymptomatic individuals with TOD or high total CV risk |
| Identification of WCE in hypertensive individuals |
| Wide variation of office BP in the same medical visit or in different visits |
| Postural, postprandial, siesta or drug-induced hypotension |
| High office BP or suspected preeclampsia in pregnant women |
| Confirmation of resistant hypertension |
| Significant disagreement between office and outside-the-office BP |
| Assessment of BP descent during sleep |
| Suspected AH or usual lack of BP descent during sleep in individuals with sleep apnea, CKD or diabetes |
| Assessment of BP variability |
AH: arterial hypertension; MH: masked hypertension; TOD: target-organ damage; WCE: white coat effect; CKD: chronic kidney disease.
Figure 1Flowchart for the diagnosis of arterial hypertension (modified from Canadian Hypertension Education Program). Laboratory assessment recommended in Chapter 3. ** Cardiovascular risk stratification recommended in Chapter 3.
Classification of BP according to casual or office measurement from 18 years of age onwards
| Classification | SBP (mm Hg) | DBP (mm Hg) |
|---|---|---|
| Normal | ≤ 120 | ≤ 80 |
| Prehypertension | 121-139 | 81-89 |
| Stage 1 hypertension | 140 – 159 | 90 – 99 |
| Stage 2 hypertension | 160 – 179 | 100 - 109 |
| Stage 3 hypertension | ≥ 180 | ≥ 110 |
| When SBP and DBP are in different categories, the highest should be used to classify BP. | ||
Isolated systolic hypertension: SBP ≥ 140 mm Hg and DBP < 90 mm Hg, and is should be classified into stages 1, 2 and 3.
Figure 2Diagnostic possibilities based on casual BP measurement, ABPM or HBPM. *Consider the diagnosis of prehypertension for casual SBP levels between 121 and 139 and/or DBP between 81 and 89 mm Hg.
Summary of the recommendations
| Recommendations | Grade of recommendation | Level of evidence |
|---|---|---|
| Screening and diagnosis of AH with office BP measurement. | I | B |
| Diagnosis of SAH based on at least two BP readings per visit, in at least two visits. | I | C |
| Measuring BP outside the office should be considered to
confirm the diagnosis of | IIa | B |
| Outside-the-office BP, ABPM or HBPM can be considered,
depending on indication, availability, easiness, | IIb | C |